AtriCure, Inc. (ATRC) Financials

ATRC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 676.6 million 160.2 million
March 31, 2026 644.0 million 152.3 million
Dec. 31, 2025 654.2 million 162.2 million
Sept. 30, 2025 635.4 million 158.9 million

ATRC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 18.4 million 12.3 million
March 31, 2026 -7.8 million 11.3 million
Dec. 31, 2025 23.4 million 11.3 million
Sept. 30, 2025 24.1 million 12.4 million

ATRC Net Income

No data available :(

ATRC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 167.8 million 61.0 million 10.0 million
March 31, 2026 146.2 million 61.0 million 10.8 million
Dec. 31, 2025 167.4 million 73.4 million 11.5 million
Sept. 30, 2025 147.9 million 61.9 million 14.9 million

ATRC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 49.1 million
March 31, 2026 49.0 million
Dec. 31, 2025 48.9 million
Sept. 30, 2025 47.7 million

ATRC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3.8 million 26.4 million 82.6 million -
March 31, 2026 3.9 million 24.2 million 84.6 million -
Dec. 31, 2025 3.4 million 22.7 million 78.3 million -
Sept. 30, 2025 2.6 million 22.9 million 78.2 million -

ATRC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 153.6 million 35.0 million
March 31, 2026 141.2 million 31.9 million
Dec. 31, 2025 140.5 million 35.9 million
Sept. 30, 2025 134.3 million 32.9 million

ATRC

Price: $57.03

52 week price:
25.36
61.70

Payout Ratio Range:
-35.29%
-2.58%

Earnings Per Share: 0.21 USD

P/E Ratio: 194.71

Exchange: NGM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 186700

Ebitda: -4.4 million

Market Capitalization: 2.7 billion

Links: